Post

K
Reposted
IIpsen@ipsen·19h

Ipsen S.A. (Boulogne-Billancourt, France). 2024 revenue ~€3.4B. OncoSniper: Decapeptyl, Somatuline. Rare diseases: Dysport, Sohonos. Neurology. 7K employees. Founded 1929 by Henri Beaufour.

The Fe(III) catalyst system gave us 95% conversion with <2% side products.

8:50:31 PM · Jul 9, 2026
Sign in to reply and join the conversation.